DE69132392D1 - Pharmazeutische zusammensetzungen von gallium-komplexen von 3-hydroxy-4-pyronen - Google Patents

Pharmazeutische zusammensetzungen von gallium-komplexen von 3-hydroxy-4-pyronen

Info

Publication number
DE69132392D1
DE69132392D1 DE69132392T DE69132392T DE69132392D1 DE 69132392 D1 DE69132392 D1 DE 69132392D1 DE 69132392 T DE69132392 T DE 69132392T DE 69132392 T DE69132392 T DE 69132392T DE 69132392 D1 DE69132392 D1 DE 69132392D1
Authority
DE
Germany
Prior art keywords
gallium
pharmaceutical compositions
hydroxy
pyron
certain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69132392T
Other languages
English (en)
Other versions
DE69132392T2 (de
Inventor
Lawrence Richard Bernstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69132392D1 publication Critical patent/DE69132392D1/de
Publication of DE69132392T2 publication Critical patent/DE69132392T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69132392T 1991-11-12 1991-11-12 Pharmazeutische zusammensetzungen von gallium-komplexen von 3-hydroxy-4-pyronen Expired - Lifetime DE69132392T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002122908A CA2122908C (en) 1991-11-12 1991-11-12 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
PCT/US1991/008239 WO1993009776A1 (en) 1991-11-12 1991-11-12 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones

Publications (2)

Publication Number Publication Date
DE69132392D1 true DE69132392D1 (de) 2000-10-05
DE69132392T2 DE69132392T2 (de) 2001-06-07

Family

ID=25677246

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69132392T Expired - Lifetime DE69132392T2 (de) 1991-11-12 1991-11-12 Pharmazeutische zusammensetzungen von gallium-komplexen von 3-hydroxy-4-pyronen

Country Status (10)

Country Link
EP (1) EP0612246B1 (de)
JP (1) JP3348849B2 (de)
KR (1) KR100217001B1 (de)
AT (1) ATE195868T1 (de)
CA (1) CA2122908C (de)
DE (1) DE69132392T2 (de)
DK (1) DK0612246T3 (de)
ES (1) ES2151486T3 (de)
GR (1) GR3034862T3 (de)
WO (1) WO1993009776A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747482A (en) * 1996-07-30 1998-05-05 Bernstein; Lawrence R. Methods and compositions to inhibit keratinocyte proliferation
EP1218011B1 (de) * 1999-10-04 2007-01-10 Lawrence R. Bernstein Gallium komplexe von 3-hydroxy-4-pyronen zur behandlung von durch intrazelluläre prokaryoten, dns- und retro-viren verursachten infektionen
DE10113185A1 (de) * 2001-03-19 2002-10-24 Faustus Forschungs Cie Zusammensetzung, enthaltend einen Gallium(III)-Komplex und einen therapeutisch wirksamen Platin-Komplex
WO2005058331A1 (en) * 2003-12-17 2005-06-30 Titan Pharmaceuticals, Inc. Use of gallium to treat inflammatory arthritis
NZ595482A (en) * 2009-03-30 2013-09-27 Niiki Pharma Inc Method of treating osteoporosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
GB9006522D0 (en) * 1990-03-23 1990-05-23 Hider Robert C Metal complexes
WO1991017751A1 (en) * 1990-05-24 1991-11-28 Fujisawa, Inc. Orally administrable gallium compositions and methods of treatment therewith

Also Published As

Publication number Publication date
CA2122908C (en) 2004-08-17
EP0612246A4 (de) 1995-04-19
KR100217001B1 (ko) 1999-09-01
ES2151486T3 (es) 2001-01-01
DE69132392T2 (de) 2001-06-07
EP0612246A1 (de) 1994-08-31
CA2122908A1 (en) 1993-05-27
WO1993009776A1 (en) 1993-05-27
ATE195868T1 (de) 2000-09-15
EP0612246B1 (de) 2000-08-30
JPH07504153A (ja) 1995-05-11
DK0612246T3 (da) 2000-12-27
GR3034862T3 (en) 2001-02-28
JP3348849B2 (ja) 2002-11-20

Similar Documents

Publication Publication Date Title
KR940703676A (ko) 알렌드로네이트를 사용한 치근막 질환의 치료방법(Treatment of periodontal disease with alendronate)
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
NL990012I2 (nl) Geneesmiddelen die salmeterol en fluticason bevatten.
BG104727A (en) Pharmaceutical composition of topiramate
DK0509317T3 (da) Lægemidler imod knoglesygdomme
BG101118A (en) Therapeutical compounds
TR200101633T2 (tr) Farmasötik bileşim
DE69002718D1 (de) Medikamente.
ES2153906T3 (es) Uso de incienso para el tratamiento de la enfermedad de alzheimer.
DE69919533D1 (de) Proteinhaltige arzneimittel
IS7006A (is) Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd
ES2136167T3 (es) Composiciones de idebenona para tratar la enfermedad de alzheimer.
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
CY1105545T1 (el) Θεραπεια στατινης για ενισχυση της διατηρησης νοητικης λειτουργιας
BR9915729A (pt) Amidas Èmega de n-arilsulfonil-aminoácido
DE69132392D1 (de) Pharmazeutische zusammensetzungen von gallium-komplexen von 3-hydroxy-4-pyronen
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
SE8704436D0 (sv) Anvendning av antisekretoriska substanser for nya indikationer
DE68916651D1 (de) Heilmittel zur behandlung von toxoplasmose.
ES2072270T3 (es) Agente farmaceutico administrable por via oral, especialmente para la terapia de substitucion de hierro y de magnesio.
BR9917605A (pt) Composição substituta de plasma
JPS554397A (en) Novel n11benzoylln22phenyll1*33diaminopropane 22ol*its manufacture and medicine containing it for therapy of acute and chronic gastritis
DE69318418D1 (de) Pharmazeutische zusammensetzungen, die 5-ht 1-rezeptoragonisten und absorptionsverstärker enthalten
TH34511A (th) สูตรผสมทางเภสัชศาสตร์ที่ประกอบด้วยสารช่วยเสริมสร้างกระดูก

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition